Articles Vol. 65 No. CĐ 3 - Bệnh viện Phổi Trung ương 15/05/2024

21. CHARACTERISTICS AND TREATMENT RESPONSE OF OUTPATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE MANAGED AT NATIONAL LUNG HOSPITAL FROM 2021 TO 2022

Vu Van Thanh1,2, Hoang Thi Viet Ha1,2
1 National Lung Hospital
2 Bệnh viện Phổi Trung ương
Corresponding author: Thanhvuvan73@gmail.com
DOI: 10.52163/yhc.v65iCD3.1117
15 Views
11 Downloads
Keywords
Chronic obstructive pulmonary disease, COPD, clinical features, risk factor.
Abstract

Introduction: Chronic obstructive pulmonary disease (COPD) is a common disease and progession over time. It is the third leading cause of death in the world. Current treatment goals are to reduce the risk of exacerbations, reduce symptoms and slow disease progression. Assessing the patient for treatable traits is the current treatment approach.

Objective: Describing the characteristics, treatment response and related factors of outpatients with COPD managed at the National Lung Hospital from 2021 to 2022. Methods: Descriptive study, conducted on 223 patients diagnosed with COPD, outpatient management at the National Lung Hospital from 1/2022 to 1/2023.

Results: Mean age of the patients was 67.63± 8.60 years, 22.9% of patients had a history of pulmonary tuberculosis, and 65,5% of patients had comorbid diseases, of which hypertension is the most common disease with a 18.8%. Patients have clinical improvement after treatment. mMRC scores before and after treatment were 2.24±0.46 and 2.11±0.48, the average number of exacerbations before treatment was 2.06±1.44 exacerbations/year, after treatment was 1.26±1.12 exacerbations/year, the difference is statistically significant. The average FEV1 decline after 12 months is 36.46±135.06 ml per year. Patients with a history of pulmonary tuberculosis, blood BCAT ≥ 300/μl, ≥ 2 exacerbations in the previous year, ≥ 2 co-morbidities are risk of FEV1 greater decline but non-significance.

Conclusion: Patients with COPD often have many comorbidities, commonly comorbidities are high blood pressure (18.8%), lipid metabolism disorders (15.7%); Patients have clinical symptom improvement and number of exacerbations per year after treatment. Patients with a history of pulmonary tuberculosis, blood BCAT ≥ 300/μl, ≥ 2 exacerbations in the previous year, ≥ 2 co-morbidities, are at increased risk of FEV1 greater decline.

References
[1]
2023 GOLD Report, Global Initiative for Chronic Google Scholar
[2]
Obstructive Lung Disease - GOLD. Accessed Google Scholar
[3]
October 23, 2023. https://goldcopd.org/2023- Google Scholar
[4]
gold-report-2/ Google Scholar
[5]
Bộ Y tế, Hướng dẫn chẩn đoán và điều trị bệnh Google Scholar
[6]
phổi tắc nghẽn mạn tính, Ban thành kèm theo Google Scholar
[7]
Quyết định số 2767/QĐ-BYT ngày 04 tháng 7 Google Scholar
[8]
năm 2023 của Bộ trưởng Bộ Y tế. Google Scholar
[9]
Trần Thị Lý, Thực trạng và hiệu quả sử dụng Google Scholar
[10]
dịch vụ quản lý, chăm sóc người bệnh phổi tắc Google Scholar
[11]
nghẽn mạn tính và hen ở một số đơn vị quản lý Google Scholar
[12]
bệnh phổi mạn tính tại Việt Nam. Luận án tiến sĩ Google Scholar
[13]
Trường ĐH Y Hà Nội, 2019. Accessed October Google Scholar
[14]
, 2023. http://dulieuso.hmu.edu.vn/handle/ Google Scholar
[15]
hmu/1908 Google Scholar
[16]
Phan Thanh Thủy, Vũ Văn Giáp, Lê Thị Tuyết Google Scholar
[17]
Lan và cs, Đặc điểm lâm sàng và tỷ lệ đợt cấp Google Scholar
[18]
bệnh phổi tắc nghẽn mạn tính của người bệnh tại Google Scholar
[19]
một số đơn vị quản lý ngoại trú. Published April Google Scholar
[20]
, 2022. Accessed October 12, 2023. https:// Google Scholar
[21]
tapchinghiencuuyhoc.vn/index.php/tcncyh/article/ Google Scholar
[22]
view/1218/807 Google Scholar
[23]
Zeng Y, Cai S, Chen Y et al., Current Status of Google Scholar
[24]
the Treatment of COPD in China: A Multicenter Google Scholar
[25]
Prospective Observational Study. Int J Chron Google Scholar
[26]
Obstruct Pulmon Dis. 2020;15:3227-3237. Google Scholar
[27]
doi:10.2147/COPD.S274024 Google Scholar
[28]
Halpin DMG, de Jong HJI, Carter V et al., Google Scholar
[29]
Distribution, Temporal Stability and Appropriateness Google Scholar
[30]
of Therapy of Patients With COPD in the UK in Relation Google Scholar
[31]
to GOLD 2019. EClinicalMedicine. 2019;14:32-41. Google Scholar
[32]
doi:10.1016/j.eclinm.2019.07.003 Google Scholar
[33]
Nguyen NV, Nguyen LP, Duong QS et al., Google Scholar
[34]
Classification of COPD as ABCD according to Google Scholar
[35]
GOLD 2011 and 2017 versions in COPD patients Google Scholar
[36]
at University Medical Center in Ho Chi Google Scholar
[37]
Minh City, Vietnam. Monaldi Arch Chest Dis. Google Scholar
[38]
Published online July 28, 2023. doi:10.4081/ Google Scholar
[39]
monaldi.2023.2619 Google Scholar
[40]
Kirkby J, Nenna R, McGowan A, Changes Google Scholar
[41]
in FEV1 over time in COPD and the importance of Google Scholar
[42]
spirometry reference ranges: The devil is in the Google Scholar
[43]
detail. Breathe. 2019;15(4):337-339. Google Scholar
[44]
doi:10.1183/20734735.0252-2019 Google Scholar